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a b s t r a c t
The abuse of methylenedioxymethamphetamine (MDMA) during pregnancy is of concern.
MDMA treatment of rats during a period of brain growth analogous to late human gestation
leads to neurochemical and behavioral changes. MDMA from postnatal day (P)11–20 in rats
produces reductions in serotonin and deﬁcits in spatial and route-based navigation. In this
experiment we examined the impact of MDMA from P11 to P20 (20 mg/kg twice daily, 8 h
apart) on neuronal architecture. Golgi impregnated sections showed signiﬁcant changes.
In the nucleus accumbens, the dendrites were shorter with fewer spines, whereas in the
dentate gyrus the dendritic length was decreased but with more spines, and for the entorhinal cortex, reductions in basilar and apical dendritic lengths in MDMA animals compared
with saline animals were seen. The data show that neuronal cytoarchitectural changes are
long-lasting following developmental MDMA exposure and are in regions consistent with
the learning and memory deﬁcits observed in such animals.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

1. Introduction
(±)-3,4-Methylenedioxymethamphetamine (MDMA)
can alter neurotransmitter and hormonal systems [1]
as well as impair cognitive function among users. These
cognitive changes in users can occur not only during
the period of drug ingestion but for protracted periods
thereafter [2–7]. Worldwide, the largest demographic to

Abbreviations: 5-HT, serotonin; ANOVA, analysis of variance; CWM,
Cincinnati water maze; DG, dentate gyrus; EC, entorhinal cortex; MDMA,
methylenedioxymethamphetamine; MWM, Morris water maze; NAcc,
nucleus accumbens; P, postnatal day; SAL, saline.
∗ Corresponding author at: Division of Neurology, MLC 7044, Cincinnati Children’s Research Foundation, 3333 Burnet Avenue, Cincinnati, OH
45229-3039, United States. Tel.: +1 513 636 8624; fax: +1 513 636 3912.
E-mail address: michael.williams@cchmc.org (M.T. Williams).

abuse MDMA is young adults of reproductive age [8,9].
Those who take MDMA may be at risk for unintended
pregnancy [10–14]. In consideration of the negative
effects produced by MDMA in adults, there is concern that
fetal exposure to MDMA may adversely affect children’s
physical and/or cognitive development. Nonetheless, few
human studies have been undertaken to examine the
impact of MDMA during gestation on neurodevelopmental
outcomes, even though such exposures are known to
occur [12,15–17], as MDMA easily crosses the placenta
[18]. Most studies have examined children only within
the perinatal period for physical abnormalities and not for
cognitive function [16,17]. A newer study examined early
mental development following prenatal MDMA exposure
and found the amount of drug exposure predicted poorer
outcomes when the children were assessed within their
ﬁrst year of life [19]. Another substituted amphetamine

http://dx.doi.org/10.1016/j.toxrep.2014.08.018
2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/3.0/).
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of abuse, methamphetamine, has been shown to result in
deﬁcits in cognitive function, motoric performance at 1
year, and volumetric and physiological changes to regions
of the brain in children following gestational exposure
[20–24]. As MDMA demonstrates different effects on
neurotransmitter and hormonal systems when compared
with methamphetamine, it is unknown whether similar
changes occur in children exposed in utero to MDMA.
In rats it has been shown that MDMA exposure, during
a period of brain development similar to late gestational
human in utero brain development [25], produces cognitive deﬁcits in the Morris water maze (MWM), a test
of spatial learning and memory and the Cincinnati water
maze (CWM), a test of egocentric route-based learning
[26–32]. These effects are not the result of MDMA-induced
body weight reductions, injection stress, or changes in
maternal care [32]. Furthermore, the deﬁcits emerge early
and for spatial learning are evident for at least a year
[28]. Interestingly, some of these effects may be dependent upon the pattern of drug administration [31]. The
underlying mechanisms for these changes, however, are
not known. There is evidence that this exposure (postnatal
days (P)11–20) causes reductions in monoamines during
both the neonatal period and in adulthood [26,33–36]. Further, neonatally MDMA-exposed animals have reductions
in cAMP-dependent protein kinase A activity and altered
5-HT1A receptor activation when assessed in adulthood
[33]. It is not known whether these biochemical effects
are accompanied by neuroanatomical changes in regions
important for spatial learning or egocentric learning.
Spatial learning in the MWM requires a properly
functioning hippocampus [37] and related regions that participate in allocentric mapping (e.g., [38]). Route-based
learning, on the other hand, requires primarily nonhippocampal regions, including the entorhinal cortex (EC),
dorsal striatum, and presubiculum [39–41]. The purpose
of this experiment was to investigate whether long-term
changes in the cytoarchitecture of brain regions important
in learning, memory, and reinforcement occur after a dosing regimen of MDMA that is known to induce learning
and memory deﬁcits. The nucleus accumbens (NAcc) was
included since we and others showed this to be a vulnerable area to amphetamines [42–44], and data showing that
the NAcc can affect both spatial and egocentric learning and
memory [45–49]. Doses were selected to be comparable to
human prenatal exposure based on an interspecies exposure scaling algorithm (reviewed in [29]). Because we have
shown that a number of control procedures such as injection stress and body weight reductions do not play a role
in the long-lasting learning and memory deﬁcits following MDMA [32], we limited comparisons to MDMA and the
vehicle-treated saline controls and did not include uninjected controls.
2. Material and methods
2.1. Subjects
Prior to experimentation, all procedures were approved
by the Cincinnati Children’s Research Foundation’s Institutional Animal Care and Use Committee and all efforts were

taken to minimize discomfort and/or pain and conformed
to the National Institutes of Health guidelines for animal
use. The vivarium was fully accredited by the Association
for the Assessment and Accreditation of Laboratory Animal
Care. The vivarium was maintained on a 14 h light/10 h dark
cycle (lights on at 600 h) and food and water were freely
available. Nulliparous female and male Sprague–Dawley
CD International Genetic Standard rats (Charles River Laboratories, Raleigh, NC) were mated in hanging wire cages
following an acclimation period to the vivarium of at least
1 week. The day a sperm plug was detected was considered embryonic day 0. Fourteen days after being placed
with the males, females were transferred to polycarbonate
cages (46 cm × 24 cm × 20 cm) with woodchip bedding. The
day of birth was considered P0 and on P1 litters were standardized to 8 pups balanced for 4 males and 4 females to
the extent possible. Offspring were weighed weekly and
uniquely identiﬁed by an ear punch on P11. The offspring
were the subjects for these experiments and were randomly selected for inclusion using a random numbers table.
Lab personal were blind to treatment group assignment.
2.2. (±)-3,4-Methylenedioxymethamphetamine
treatment
(±)-3,4-Methylenedioxymethamphetamine
HCl
(expressed as the freebase and greater than 95% pure)
was obtained from the National Institute on Drug Abuse
through its provider Research Triangle Institute (Research
Triangle Park, NC). MDMA was dissolved in sterile isotonic saline (SAL) at a concentration of 20 mg/3 ml and
administered to animals at a dose of 20 mg/kg through a
subcutaneous route in the dorsum. MDMA was delivered
twice daily from P11 to P20 with an 8 h interval between
treatments. Irritation to the dermis was minimized by
varying injection sites. Prior to each injection, animals
were weighed. Animals were weaned naturally by their
dams [50,51] and separated on P28 and housed in pairs. A
total of six litters were prepared for this study and only a
single pair of males (1 MDMA-treated and 1 SAL-treated)
was used from each litter in a split-litter design.
2.3. Golgi–Cox analysis
On approximately P60 (a day that is encompassed by
our previous behavioral testing periods, see [29]) the animals were given an overdose of sodium pentobarbital and
perfused intracardially with physiological saline using a
Masterﬂex pump (Cole Palmer, Vernon Hills, IL). Littermates (i.e., 1 MDMA and 1 SAL animal) were perfused
simultaneously and following 10 min of perfusion, whole
brains were removed. Brains were placed in Golgi–Cox
solution for 14 days and subsequently in a Golgi–Cox/30%
sucrose solution for 3 days. The tissues were cut in 200 m
sections using a vibratome, and sections were mounted on
gelatinized slides and stained using the method described
previously [52]. Neurons were identiﬁed at a lower magniﬁcation (100×) in each hemisphere and then ﬁve neurons
per hemisphere in each region of interest were traced at
a higher magniﬁcation (250×) using the camera lucida
method. An experimenter, blinded to treatment, performed
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the cell selection and tracings. In order for a neuron to be
selected it had to have a dendritic tree that was well visualized and not obscured by stain precipitate, blood vessels,
or astrocytes. If more than ﬁve neurons were identiﬁed
in each hemisphere as reaching these criteria, then the
cells included were randomly selected from the total number of cells identiﬁed. Four brain areas were traced and
quantiﬁed, these were as follows: EC (Layer II), nucleus
accumbens shell (NAcc), and the dentate gyrus (DG), and
only dendritic lengths were examined in Layer V of the
medial frontal cortex (Zilles Cg3). Pyramidal cells were
traced in the cortical regions, granule cells in the DG,
and medium spiny neurons in the NAcc. These regions
were selected based on the behavioral phenotype that
animals display following exposure to MDMA during the
same neonatal period as used here, namely impairments
in spatial learning and route-based egocentric learning
[26–28,31,32].
Dendritic length was quantiﬁed using a Sholl analysis
of ring intersections [53]. For example, to obtain a measure of length and complexity, the total number of ring
intersections was summed and then averaged across cells.
Spine density was quantiﬁed by counting spines on one
fourth-order terminal tip from basilar dendrites and one
third-order terminal tip from apical dendrites in the cortex.
These regions of the dendrites were used for analysis since
this is typically where differences have been observed in
past studies following psychostimulant administration in
adult and developing rats [43,44,54]. Secondly, when there
are increases in dendritic length it most often occurs in
the distal end, thus, increasing the likelihood of changes
in dendritic spine densities at this location. Neither NAcc
nor DG neurons have apical and basilar dendritic trees,
therefore, spine density was quantiﬁed using a third-order
terminal tip in these regions. Spine density was consistently performed on the same branch order and counted
as the number of spines/10 m of the dendritic branch.
The magniﬁcation factor for the analysis of spine density
was 1000×. The morphological analyses were performed
by personnel blind to the treatment group of the animals.

2.4. Statistics
Because litter effects are an important source of variance in developmental studies [55], data were analyzed
using a mixed general linear model analysis of variance
(ANOVA; SAS 9.1 Proc Mixed, Cary, NC). In this model,
litter was a blocking factor. For some brain regions, neurons were either not stained completely or no staining was
present and therefore the number of animals represented
was 4–6/treatment. With litter accounted for in the block
factor, treatment was a between factor and hemisphere
was a repeated measure factor. Signiﬁcant interactions
were analyzed using t-tests generated by Proc Mixed. Proc
Mixed provides adjusted degrees of freedom using the
Kenward–Roger method. Speciﬁc regions were analyzed
separately as were basilar and apical dendritic trees. Data
are presented as mean ± SEM and statistical signiﬁcance
was accepted at p ≤ 0.05 and only signiﬁcant Treatment or
Treatment interactions are reported.
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3. Results
Fig. 1 shows camera lucida drawings of representative
neurons in the NAcc (Fig. 1A and B), DG (Fig. 1C and D), and
EC (Fig. 1E and F) for both SAL- and MDMA-treated animals.
In the NAcc, there were signiﬁcant effects of Treatment (F(1,5) = 49.55, p < 0.001). The MDMA-treated animals
had shorter dendritic lengths than the SAL-treated animals
(Fig. 2 top). Similarly, the MDMA-treated animals had fewer
dendritic spines than the SAL-treated animals (F(1,5) = 9.06,
p < 0.03 (Fig. 2 bottom)). No interaction for dendritic length
or number of spines was observed.
In the DG the dendritic length was shorter in the MDMAtreated animals [Treatment, F(1,10.2) = 5.89, p < 0.04 (Fig. 3
top)], whereas the number of spines was increased
in the MDMA-treated animals compared with SALtreated animals [Treatment, F(1,4.2) = 9.97, p < 0.04 (Fig. 3
bottom)]. There was a signiﬁcant interaction of Treatment × Hemisphere (F(1,9) = 9.75, p < 0.02), however, irrespective of laterality, both hemispheres in the MDMAtreated animals showed an increase in spine number
compared with the SAL-treated animals (not shown).
In the EC there were signiﬁcant effects of Treatment
for both the basilar (F(1,5) = 18.1, p < 0.01) and apical
(F(1,5) = 13.97, p < 0.02) dendritic lengths. The MDMAtreated animals had a reduction in dendritic length in both
the basilar (Fig. 4A) and apical (Fig. 4B) branches compared with SAL-treated animals. No other differences were
observed for either the basilar or apical dendrites. Contrary
to the differences in length, no differences were observed
for the number of basilar (Fig. 4C) or apical (Fig. 4D) spines.
In order to determine if the changes in dendritic length
were speciﬁc to the EC we also examined the length of the
basilar and apical branches in the frontal cortex. Unlike the
EC, no differences in dendritic length were observed in the
frontal cortex between MDMA- and SAL-treated animals
(not shown).
4. Discussion
Exposure to MDMA in neonatal rats leads to persistent
deﬁcits in the ability of the animals to perform similarly
to control animals in various cognitive tests. Speciﬁcally,
deﬁcits are observed in spatial learning in the MWM and
Barnes maze, in the CWM when run under bright light with
visible distal cues and when run under infrared light with
no visible cues (see [29]). Taken together, the data suggest that multiple regions of the brain are permanently
affected by MDMA administration during the neonatal
period. Because of the known learning deﬁcits, we examined several regions of interest, including the DG, NAcc, and
EC, and show that long-term changes in neuronal architecture are present in these regions, regions important for
spatial and egocentric learning and memory, and at an age
when learning and memory deﬁcits have previously been
demonstrated.
While mechanisms underlying the deﬁcits in learning and memory are unknown following neonatal MDMA
exposure, there are disruptions to multiple systems during and after the exposure period used here. For example,
we have demonstrated that monoamines and especially
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Fig. 1. Displayed are representative camera lucida tracings of nucleus accumbens pyramidal cells (A and B), dentate gyrus granular cells (C and D), and
neurons from Layer II of the entorhinal cortex (E and F) from animals treated neonatally with MDMA (A, C, and E) or SAL (B, D, and F).

serotonin (5-HT) are depleted both during and following neonatal exposure to MDMA [33–36]. This reduction
appears to ﬂuctuate over time but remains decreased
in the hippocampus through adulthood. Others have
demonstrated that exposure on P3 or P4 to agents that
cause transient (para-chloroamphetamine) or permanent
(5,7-dihydroxytryptamine) depletions in 5-HT produces
reductions in spines without changes to the length of
the neuron in the DG [56]. In contrast, in the present
experiment MDMA administration increased the number of spines in this region and decreased length. While
the timing of the 5-HT depletions differs between these
studies by almost a week, there may be factors other
than 5-HT that are affecting the MDMA-treated animals. MDMA is not a purely serotonergic drug and can
affect other neurotransmitter systems (Rothman et al.,
2001). While dopamine levels are similar to controls
during the neonatal period of MDMA administration, 3,4dihydroxyphenylacetic acid levels are changed [36,57],
suggesting an impact of MDMA on dopamine metabolism.
In adulthood, the animals treated as neonates with MDMA
show decreases in dopamine in the prefrontal cortex and
striatum [33], but see [27]. This change in dopamine may
be important since we have shown that drugs that deplete
dopamine in the striatum in adulthood produce learning
and memory deﬁcits in the CWM [58,59]. Therefore, either
the early changes in dopaminergic metabolism, or the later
decreases in dopamine, may underlie learning deﬁcits in
the CWM. It should be noted that animals treated with
MDMA from P11 to P20 also demonstrate hypoactivity
[27,60], further implicating dopamine as playing some role
in cognitive deﬁcits produced by neonatal MDMA despite
the fact that locomotor hypoactivity did not translate to
any changes in swim speed during water maze testing.

We have shown that neonatal rats treated with
methamphetamine from P11 to P20 have similar changes
in the NAcc as those treated with MDMA during this same
period; that is, decreased dendritic length and spine density. MA-treated and MDMA-treated animals both had an
∼16% decrease in dendritic length in the NAcc, whereas
for number of spines, MA-treated animals had an ∼10%
decrease and the MDMA-treated animals had an ∼17%
decrease. In the DG, the two drugs produced different
effects. For example, MA only produced an ∼11% decrease
in spines in the DG, whereas MDMA produced an ∼45%
increase in spine density in this region and an ∼13%
decrease in length. Interestingly, MDMA-treated animals
tend to have greater deﬁcits than MA-treated animals in the
MWM (see [35,44] for comparison), a hippocampally modulated behavior [37,61]. It should also be pointed out that
when there were differences in the magnitude of an effect,
the MDMA-treated animals appear to be more affected
than MA-treated animals. Animals that were exposed to
a developmental stressor, maternal separation from P3 to
P21, show increased spine density in the NAcc [62], lending further support to the idea that the changes observed
here are biologically relevant. Neither drug had an effect
on the frontal cortex. The EC was not examined following
methamphetamine exposure so a comparison between the
two drugs cannot be made for this region. The EC is a region
important in egocentric learning and memory [41,63]. The
changes in the EC may be important for explaining the
learning deﬁcits in the CWM. This is the ﬁrst study to our
knowledge to examine the EC of adult rats that were neonatally exposed to a substituted amphetamine.
In adult animals, others have examined the change in
neuronal architecture following multiple days of MDMA
exposure. Whereas dendritic length in the NAcc was not
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Fig. 2. Total Sholl ring intersections in the NAcc (top) were decreased
in animals treated with MDMA from P11 to P20 compared with saline
(SAL) animals (p < 0.001), and the number of spines (bottom) in this region
was also decreased in the MDMA-treated animals versus SAL animals
(p < 0.05). *p < 0.05, ***p < 0.001.

changed in adult MDMA-treated animals, the number of
spines in the shell was increased [64]; a similar effect
was demonstrated in the dorsal striatum of adult animals that were administered MDMA [65]. Furthermore,
adult animals have small changes in the prefrontal cortex for the composition of neurons and the number of
spines, where the effect (i.e., increases or decreases) in
the number of spines was dependent upon the branching of the dendrite [64]. Adult animals treated with
MDMA do not demonstrate egocentric route-based learning and memory deﬁcits [59] or spatial learning deﬁcits
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Fig. 3. Total Sholl ring intersections in the dentate gyrus (top) were
decreased in animals treated with MDMA from P11 to P20 compared with
saline (SAL) controls (p < 0.05), whereas the number of spines (bottom) in
this region was increased in the MDMA-treated animals versus SAL control
(p < 0.05). *p < 0.05.

[66] as seen in animals treated neonatally (see [29]).
Rather, adult animals have deﬁcits in the CWM only when
tested with distal cues present but not when distal cues
are removed [66,67]. While procedural differences may
account for the differences in effects between adult and
neonatal administration of MDMA, the most important difference appears to be the period of development when
animals are treated. Taken together, these data implicate
the decreases in spine number and dendritic length as
factors that may contribute to the learning and memory
deﬁcits of animals treated neonatally with MDMA. The
changes in morphology of Golgi-stained dendrites provide
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Fig. 4. In the entorhinal cortex total Sholl ring intersections were decreased in both the basilar (A) and apical (B) dendrites in neonatally MDMA-treated
animals compared with SAL-treated animals (p < 0.01 and p < 0.05, respectively). No differences were noted in the number of spines in either the basilar
(C) or apical (D) projections. *p < 0.05, **p < 0.01.

initial evidence of altered synaptic connectivity [42]. In
support of the idea that changes in dendritic spines are
affected by learning, in humans, the amount of education
a person has correlates with dendritic length, such that
those with more than a high school education have longer
dendritic lengths than those with only a high school education, and these both have longer dendritic lengths than
those without a high school education [68]. In addition,
it has been suggested that changes in dendritic synaptic
morphology are indicative of a particular disease state for
various neurological disorders whether, for example, from
Alzheimer’s disease or drug addiction [69]. This is relevant to the present study since neonatal MDMA exposure
produces allocentric and egocentric learning impairments
concurrently with decreases in dendritic length and spine
density in brain regions implicated as important for these
two types of learning and memory. The hippocampus, prefrontal cortex, and entorhinal cortex all project to the NAcc
(for review, [70]), and the changes observed in the NAcc

may point to synaptic connectivity changes that impair
learning and memory in MDMA-treated animals.
There are limitations to this study. The animals were
examined in adulthood, therefore the developmental time
course for these cytoarchitectural changes is unknown.
However, if the morphological changes precede the learning and memory deﬁcits, then learning and memory
changes should appear very early and indeed we have
shown that allocentric and egocentric learning and memory deﬁcits in MDMA-treated animals are present as early
as P30 [28]. We used a single dose of MDMA and only one
exposure period. We used this dose because it consistently
produces learning and memory deﬁcits when given as a
single or divided daily dose during the P11–20 exposure
period [31]. We did not examine animals after learning and
memory testing to determine if the morphological changes
could be directly correlated to the learning and memory
deﬁcits; this must await further study now that morphological effects have been found.
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In conclusion, the results show that neonatal MDMA
exposure produces speciﬁc changes within the brain in
regions that play essential roles in allocentric and egocentric learning and memory. It is recognized that Golgi
staining is suggestive for loss or increase of synaptic
connectivity, and that further investigation is needed.
Nonetheless, the changes in spine densities and dendritic lengths suggest long-term synaptic reorganization
following early MDMA exposure during a period that is
approximately analogous to late gestational human brain
development.
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